Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 3

2(40.0%)

5Total

N/A(3)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT07400497Not ApplicableRecruiting

Family Foundations for Special Education Trial

Role: collaborator

NCT04692519Not ApplicableUnknown

Duet 2.0 Starting the Conversation: A New Intervention Model to Stimulate Language Growth in Underserved Populations

Role: collaborator

NCT02713659Not ApplicableCompleted

Early Literacy Promotion Intervention

Role: collaborator

NCT00231179Phase 3Completed

The MOM Program: 5 Year Follow-up Study of a Home Visiting Program at The Children's Hospital of Philadelphia

Role: collaborator

NCT00970853Phase 3Completed

MOM Program 8-Year Follow-up

Role: collaborator

All 5 trials loaded